making new medical technologies available in Hungary

Boston Scientific Receives FDA Approval for WATCHMAN™ Left Atrial Appendage Closure Device

First-Of-Its-Kind Alternative to Long-Term Warfarin Therapy for Stroke Risk Reduction in Patients with Non-Valvular Atrial Fibrillation Mar 13, 2015 MARLBOROUGH, Mass., March 13, 2015 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration...
READ MORE

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

Novel Stroke Risk Reduction Option for Indicated Patients with Atrial Fibrillation Mar 24, 2015 MARLBOROUGH, Mass., March 24, 2015 /PRNewswire/ — This week, four patients in the United States received the first implants of the Boston Scientific Corporation (NYSE: BSX) WATCHMAN™ Left...
READ MORE

EVOLVE II Trial Represents the First Successful U.S. Pivotal Trial of a Bioabsorbable Polymer Stent .

EVOLVE II Trial Represents the First Successful U.S. Pivotal Trial of a Bioabsorbable Polymer Stent . In the first successful U.S. pivotal trial of a bioabsorbable polymer stent, the Boston Scientific (NYSE: BSX) SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent...
READ MORE

Boston Scientific Announces Schedule For Presentations At The Upcoming North American Neuromodulation Society (NANS) Meeting

Data Will Focus on Long-Term Back Pain Relief Using the Boston Scientific Precision Spectra™ Spinal Cord Stimulator (SCS) System and Highlight Research on Stimulation Waveforms   Boston Scientific CorporationNovember 3, 2014 9:00 AM   ARLBOROUGH, Mass., Nov. 3, 2014 /PRNewswire/ —...
READ MORE

Successful stroke care can save thousands of lives

A paper named “Interactions Within Stroke Systems of Care was published Aug. 29 by the American Heart Association and the American Stroke Association. According to the study, government agencies, health care authorities, and medical leaders should support the formation and certification of...
READ MORE

New ESH/ESC guidelines for the management of hypertension

New joint guidelines for hypertension were published by the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) on June 15th in which several significant changes to hypertension treatment were recommended.
READ MORE